Back
Evoke Pharma Vs. Eli Lilly and Industry Stock Comparison
Sell
17
EVOK
Evoke Pharma
Last Price:
4.56
Seasonality Move:
12.83%
Sell
37
LLY
Eli Lilly and
Last Price:
786.07
Seasonality Move:
3.42%
Sell
17
Evoke Pharma (EVOK)
is a Sell
Is Evoke Pharma a Buy, Sell or Hold?
- The current Evoke Pharma [EVOK] share price is $4.37. The Score for EVOK is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
- EVOK is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
37
Eli Lilly and (LLY)
is a Sell
Is Eli Lilly and a Buy, Sell or Hold?
- The current Eli Lilly and [LLY] share price is $786.23. The Score for LLY is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- LLY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EVOK Stock Price Chart
What is Evoke Pharma's stock price today?
-
The Evoke Pharma share price today is $4.37
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EVOK is experiencing slight selling pressure.
LLY Stock Price Chart
What is Eli Lilly and's stock price today?
-
The Eli Lilly and share price today is $786.23
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LLY is experiencing selling pressure, which indicates risk of future bearish movement.
EVOK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.1 | Sell |
Relative Strength Index (14 RSI): | 35.88 | Sell |
Chaikin Money Flow: | -25306 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.9 - 6.06) | Sell |
Bollinger Bands (100): | (4.53 - 6.19) | Sell |
LLY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -26.74 | Sell |
Relative Strength Index (14 RSI): | 31.99 | Sell |
Chaikin Money Flow: | -3083339 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (812.82 - 913.9) | Sell |
Bollinger Bands (100): | (840.04 - 940.44) | Sell |
EVOK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.25 | Sell |
20-day SMA: | 5.56 | Sell |
50-day SMA: | 5.07 | Sell |
200-day SMA: | 6.07 | Sell |
8-day EMA: | 5.06 | Sell |
20-day EMA: | 5.34 | Sell |
50-day EMA: | 5.29 | Sell |
200-day EMA: | 7.33 | Sell |
LLY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 807.6 | Sell |
20-day SMA: | 849.11 | Sell |
50-day SMA: | 885.61 | Sell |
200-day SMA: | 833.2 | Sell |
8-day EMA: | 813.19 | Sell |
20-day EMA: | 839.74 | Sell |
50-day EMA: | 869.11 | Sell |
200-day EMA: | 815.35 | Sell |
Evoke Pharma Earnings Growth & EVOK Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $22.78 per share, and an increase next year of $4.46 per share.
Eli Lilly and Earnings Growth & LLY Earnings Dates
- Analysts estimate an earnings increase this quarter of $3.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.90 per share, and an increase next year of $9.45 per share.
Evoke Pharma Technical Analysis
Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Eli Lilly and Technical Analysis
Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |